APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neprilysin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025175 pages

Choose your research edition.

Industry ResearchNeprilysin Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Neprilysin Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neprilysin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neprilysin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neprilysin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neprilysin include Novartis AG, Theravance Biopharma Inc, Pharmaleads SA and Bioprojet SCR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neprilysin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neprilysin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neprilysin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neprilysin market size, projected growth trends, production technologies, key applications, and end-use industries.

Neprilysin Segment by Company

Novartis AG

Theravance Biopharma Inc

Pharmaleads SA

Bioprojet SCR

Neprilysin Segment by Type

TD-0714

STR-324

PL-265

LHW-090

Others

Neprilysin Segment by Application

Acute Heart Failure

Hypertension

Cancer Pain

Alzheimer's Disease

Others

Neprilysin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neprilysin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neprilysin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neprilysin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neprilysin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neprilysin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neprilysin Industry Trends Table 2. Neprilysin Industry Drivers Table 3. Neprilysin Industry Opportunities and Challenges Table 4. Neprilysin Industry Restraints Table 5. Global Neprilysin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neprilysin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neprilysin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Neprilysin Sales Market Share by Manufacturers Table 9. Global Neprilysin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Neprilysin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neprilysin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neprilysin Manufacturers, Product Type & Application Table 13. Global Neprilysin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neprilysin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of TD-0714 Table 17. Major Manufacturers of STR-324 Table 18. Major Manufacturers of PL-265 Table 19. Major Manufacturers of LHW-090 Table 20. Major Manufacturers of Others Table 21. Global Neprilysin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Neprilysin Sales by Type (2021-2026) & (K Units) Table 23. Global Neprilysin Sales by Type (2027-2032) & (K Units) Table 24. Global Neprilysin Sales Market Share by Type (2021-2026) Table 25. Global Neprilysin Sales Market Share by Type (2027-2032) Table 26. Global Neprilysin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Neprilysin Revenue by Type (2021-2026) & (K Units) Table 28. Global Neprilysin Revenue by Type (2027-2032) & (K Units) Table 29. Global Neprilysin Revenue Market Share by Type (2021-2026) Table 30. Global Neprilysin Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Acute Heart Failure Table 32. Major Manufacturers of Hypertension Table 33. Major Manufacturers of Cancer Pain Table 34. Major Manufacturers of Alzheimer's Disease Table 35. Major Manufacturers of Others Table 36. Global Neprilysin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Neprilysin Sales by Application (2021-2026) & (K Units) Table 38. Global Neprilysin Sales by Application (2027-2032) & (K Units) Table 39. Global Neprilysin Sales Market Share by Application (2021-2026) Table 40. Global Neprilysin Sales Market Share by Application (2027-2032) Table 41. Global Neprilysin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Neprilysin Revenue by Application (2021-2026) & (K Units) Table 43. Global Neprilysin Revenue by Application (2027-2032) & (K Units) Table 44. Global Neprilysin Revenue Market Share by Application (2021-2026) Table 45. Global Neprilysin Revenue Market Share by Application (2027-2032) Table 46. Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Neprilysin Sales by Region (2021-2026) & (K Units) Table 48. Global Neprilysin Sales Market Share by Region (2021-2026) Table 49. Global Neprilysin Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Neprilysin Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Neprilysin Sales by Country (2021-2026) & (K Units) Table 53. North America Neprilysin Sales by Country (2027-2032) & (K Units) Table 54. Europe Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Neprilysin Sales by Country (2021-2026) & (K Units) Table 56. Europe Neprilysin Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Neprilysin Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Neprilysin Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Neprilysin Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Neprilysin Sales by Country (2027-2032) & (K Units) Table 63. Global Neprilysin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Neprilysin Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Neprilysin Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Neprilysin Revenue Market Share by Region (2021-2026) Table 67. Global Neprilysin Revenue Market Share by Region (2027-2032) Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Neprilysin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis AG Neprilysin Product Portfolio Table 72. Novartis AG Recent Development Table 73. Theravance Biopharma Inc Company Information Table 74. Theravance Biopharma Inc Business Overview Table 75. Theravance Biopharma Inc Neprilysin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Theravance Biopharma Inc Neprilysin Product Portfolio Table 77. Theravance Biopharma Inc Recent Development Table 78. Pharmaleads SA Company Information Table 79. Pharmaleads SA Business Overview Table 80. Pharmaleads SA Neprilysin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pharmaleads SA Neprilysin Product Portfolio Table 82. Pharmaleads SA Recent Development Table 83. Bioprojet SCR Company Information Table 84. Bioprojet SCR Business Overview Table 85. Bioprojet SCR Neprilysin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bioprojet SCR Neprilysin Product Portfolio Table 87. Bioprojet SCR Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Neprilysin Distributors List Table 91. Neprilysin Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Neprilysin Product Image Figure 2. Global Neprilysin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neprilysin Market Size (2021-2032) & (US$ Million) Figure 4. Global Neprilysin Sales (2021-2032) & (K Units) Figure 5. Global Neprilysin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neprilysin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. TD-0714 Image Figure 9. STR-324 Image Figure 10. PL-265 Image Figure 11. LHW-090 Image Figure 12. Others Image Figure 13. Global Neprilysin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Neprilysin Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Neprilysin Sales Market Share by Type (2021-2032) Figure 16. Global Neprilysin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Neprilysin Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Neprilysin Revenue Market Share by Type (2021-2032) Figure 19. Acute Heart Failure Image Figure 20. Hypertension Image Figure 21. Cancer Pain Image Figure 22. Alzheimer's Disease Image Figure 23. Others Image Figure 24. Global Neprilysin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Neprilysin Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Neprilysin Sales Market Share by Application (2021-2032) Figure 27. Global Neprilysin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Neprilysin Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Neprilysin Revenue Market Share by Application (2021-2032) Figure 30. North America Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Neprilysin Sales Market Share by Country (2021-2032) Figure 32. U.S. Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Neprilysin Sales Market Share by Country (2021-2032) Figure 37. Germany Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Neprilysin Sales Market Share by Country (2021-2032) Figure 44. China Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Neprilysin Sales Market Share by Country (2021-2032) Figure 52. Brazil Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Neprilysin Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Neprilysin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Neprilysin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Neprilysin Revenue (2021-2032) & (US$ Million) Figure 63. North America Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Neprilysin Revenue (2021-2032) & (US$ Million) Figure 65. Europe Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Neprilysin Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Neprilysin Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Neprilysin Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Neprilysin Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • TD-0714
  • STR-324
  • PL-265
  • LHW-090
  • Others
Applications
  • Acute Heart Failure
  • Hypertension
  • Cancer Pain
  • Alzheimer's Disease
  • Others
Companies covered
  • Novartis AG
  • Theravance Biopharma Inc
  • Pharmaleads SA
  • Bioprojet SCR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neprilysin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neprilysin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neprilysin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neprilysin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neprilysin Market Dynamics
  1. 2.1 Neprilysin Industry Trends
  2. 2.2 Neprilysin Industry Drivers
  3. 2.3 Neprilysin Industry Opportunities and Challenges
  4. 2.4 Neprilysin Industry Restraints
3 Neprilysin Market by Manufacturers
  1. 3.1 Global Neprilysin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neprilysin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neprilysin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neprilysin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neprilysin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neprilysin Manufacturers, Product Type & Application
  7. 3.7 Global Neprilysin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neprilysin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neprilysin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neprilysin Tier 1, Tier 2, and Tier 3
4 Neprilysin Market by Type
  1. 4.1 Neprilysin Type Introduction
  2. 4.1.1 TD-0714
  3. 4.1.2 STR-324
  4. 4.1.3 PL-265
  5. 4.1.4 LHW-090
  6. 4.1.5 Others
  7. 4.2 Global Neprilysin Sales by Type
  8. 4.2.1 Global Neprilysin Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Neprilysin Sales by Type (2021-2032)
  10. 4.2.3 Global Neprilysin Sales Market Share by Type (2021-2032)
  11. 4.3 Global Neprilysin Revenue by Type
  12. 4.3.1 Global Neprilysin Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Neprilysin Revenue by Type (2021-2032)
  14. 4.3.3 Global Neprilysin Revenue Market Share by Type (2021-2032)
5 Neprilysin Market by Application
  1. 5.1 Neprilysin Application Introduction
  2. 5.1.1 Acute Heart Failure
  3. 5.1.2 Hypertension
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Alzheimer's Disease
  6. 5.1.5 Others
  7. 5.2 Global Neprilysin Sales by Application
  8. 5.2.1 Global Neprilysin Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Neprilysin Sales by Application (2021-2032)
  10. 5.2.3 Global Neprilysin Sales Market Share by Application (2021-2032)
  11. 5.3 Global Neprilysin Revenue by Application
  12. 5.3.1 Global Neprilysin Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Neprilysin Revenue by Application (2021-2032)
  14. 5.3.3 Global Neprilysin Revenue Market Share by Application (2021-2032)
6 Global Neprilysin Sales by Region
  1. 6.1 Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neprilysin Sales by Region (2021-2032)
  3. 6.2.1 Global Neprilysin Sales by Region (2021-2026)
  4. 6.2.2 Global Neprilysin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neprilysin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neprilysin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neprilysin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neprilysin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neprilysin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neprilysin Revenue by Region
  1. 7.1 Global Neprilysin Revenue by Region
  2. 7.1.1 Global Neprilysin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neprilysin Revenue by Region (2021-2026)
  4. 7.1.3 Global Neprilysin Revenue by Region (2027-2032)
  5. 7.1.4 Global Neprilysin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neprilysin Revenue (2021-2032)
  8. 7.2.2 North America Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neprilysin Revenue (2021-2032)
  11. 7.3.2 Europe Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neprilysin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neprilysin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neprilysin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Neprilysin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Neprilysin Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Theravance Biopharma Inc
  8. 8.2.1 Theravance Biopharma Inc Company Information
  9. 8.2.2 Theravance Biopharma Inc Business Overview
  10. 8.2.3 Theravance Biopharma Inc Neprilysin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Theravance Biopharma Inc Neprilysin Product Portfolio
  12. 8.2.5 Theravance Biopharma Inc Recent Developments
  13. 8.3 Pharmaleads SA
  14. 8.3.1 Pharmaleads SA Company Information
  15. 8.3.2 Pharmaleads SA Business Overview
  16. 8.3.3 Pharmaleads SA Neprilysin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pharmaleads SA Neprilysin Product Portfolio
  18. 8.3.5 Pharmaleads SA Recent Developments
  19. 8.4 Bioprojet SCR
  20. 8.4.1 Bioprojet SCR Company Information
  21. 8.4.2 Bioprojet SCR Business Overview
  22. 8.4.3 Bioprojet SCR Neprilysin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bioprojet SCR Neprilysin Product Portfolio
  24. 8.4.5 Bioprojet SCR Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neprilysin Value Chain Analysis
  2. 9.1.1 Neprilysin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neprilysin Production Mode & Process
  6. 9.2 Neprilysin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neprilysin Distributors
  9. 9.2.3 Neprilysin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst